Literature DB >> 18185152

Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model.

Sophie J Bakri1, Jose S Pulido, Priyabata Mukherjee, Ronald J Marler, Debabrata Mukhopadhyay.   

Abstract

PURPOSE: To evaluate the retinal toxicity of intravitreal nanogold, a novel antiangiogenic and long-term delivery agent.
METHODS: One eye of each of 16 Dutch-belted rabbits was injected with intravitreal nanogold; the other eye served as a control. Eight rabbits received a dose of 67 micromol/0.1 mL of nanogold intravitreally into 1 eye; the other 8 rabbits received a dose of 670 micromol/0.1 mL of nanogold intravitreally into 1 eye. Eight rabbits were killed at 1 week, and eight were killed at 1 month; both eyes of each rabbit were enucleated. The eyes were fixed with 2% paraformaldehyde and sectioned for histologic examination.
RESULTS: In all injected and control eyes, there was mild vacuolization in the inner plexiform and ganglion cell layers. The retina and retinal pigment epithelium were otherwise histologically normal.
CONCLUSION: Intravitreal nanogold at concentrations of 67 micromol/0.1 mL and 670 micromol/0.1 mL showed no signs of retinal or optic nerve toxicity by light microscopy during histologic examination at 1 month.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18185152     DOI: 10.1097/IAE.0b013e3180dc9360

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  21 in total

1.  Nanoparticles in the ocular drug delivery.

Authors:  Hong-Yan Zhou; Ji-Long Hao; Shuang Wang; Yu Zheng; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 2.  [Use of nanoparticles in ophthalomology].

Authors:  I Hahn; P Heiduschka; E Endl; N Eter
Journal:  Ophthalmologe       Date:  2011-09       Impact factor: 1.059

3.  Green synthesis of gold nanoparticles using extracellular metabolites of fish gut microbes and their antimicrobial properties.

Authors:  T Rajasekar; K Karthika; G Muralitharan; A Maryshamya; S Sabarika; S Anbarasu; K Revathy; N Prasannabalaji; S Kumaran
Journal:  Braz J Microbiol       Date:  2020-05-18       Impact factor: 2.476

Review 4.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

Review 5.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Authors:  Anu Puri; Kristin Loomis; Brandon Smith; Jae-Ho Lee; Amichai Yavlovich; Eliahu Heldman; Robert Blumenthal
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2009       Impact factor: 4.889

Review 6.  Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications.

Authors:  Amichai Yavlovich; Brandon Smith; Kshitij Gupta; Robert Blumenthal; Anu Puri
Journal:  Mol Membr Biol       Date:  2010-10-13       Impact factor: 2.857

7.  Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits.

Authors:  Saloomeh Saati; Rajat N Agrawal; Stan Louie; Gerald J Chader; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-31       Impact factor: 3.117

8.  Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye.

Authors:  Atsushi Hayashi; Ayman Naseri; Mark E Pennesi; Eugene de Juan
Journal:  Jpn J Ophthalmol       Date:  2009-05-31       Impact factor: 2.447

9.  Molecular histopathology using gold nanorods and optical coherence tomography.

Authors:  Shradha Prabhulkar; Jared Matthews; Siddarth Rawal; Richard M Awdeh
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

10.  Comparative in vivo assessment of some adverse bioeffects of equidimensional gold and silver nanoparticles and the attenuation of nanosilver's effects with a complex of innocuous bioprotectors.

Authors:  Boris A Katsnelson; Larisa I Privalova; Vladimir B Gurvich; Oleg H Makeyev; Vladimir Ya Shur; Yakov B Beikin; Marina P Sutunkova; Ekaterina P Kireyeva; Ilzira A Minigalieva; Nadezhda V Loginova; Marina S Vasilyeva; Artem V Korotkov; Eugene A Shuman; Larisa A Vlasova; Ekaterina V Shishkina; Anastasia E Tyurnina; Roman V Kozin; Irene E Valamina; Svetlana V Pichugova; Ludmila G Tulakina
Journal:  Int J Mol Sci       Date:  2013-01-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.